ADMA - The Buzz Show: ADMA Biologics (NASDAQ: ADMA) FDA Approval for IVIG Production Scale

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale ”

ADMA Biologics (NASDAQ: ADMA) , Inc. shot up over 23% in premarket trading after the company was granted approval for an Increased Intravenous Immune Globulin Production Scale by the FDA.

The 4,400-liter IVIG plasma pool scale for BIVIGAM® will allow ADMA to expand its manufacturing plant’s total processing capacity from 400,000 liters to an anticipated peak throughput of up to 600,000 liters.

ADMA Biologics is an end-to-end American commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three FDA-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida.

For more information, please visit: ADMA Biologics, Inc.

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

The post “The Buzz” Show: ADMA Biologics (NASDAQ: ADMA) FDA Approval for IVIG Production Scale first appeared on Financial Buzz .

For further details see: